Insider filing · HALO
Cortney Caudill
SVP, CHIEF OPERATING OFFICER
profile →
Halozyme Therapeutics, Inc.
HALO · Healthcare · 39 filings in 24 months
ticker →
Cortney Caudill sold $278K of Halozyme Therapeutics (HALO)
Executed Nov 1 2025, disclosed Dec 19 2025, 48 days later, against a two-business-day limit.
Value, as filed
$278K
4,263 sh × $65.19
Executed
Nov 1 2025
the trade date, as filed
Disclosed
Dec 19 2025
48 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CCCortney Caudill (SVP, CHIEF OPERATING OFFICER) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales, 1 filed past the two-business-day deadline), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $2.0M of HALO (28,857 sh across 3 lots, as filed), executed Mar 9.
The name
HALOHealthcare · Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Cortney Caudill in HALO
HALOSALE
Halozyme Therapeutics, Inc.
$2.0M28,857 sh across 3 lots
Exec Mar 9
Filed Mar 10 · 5:30 PM ET